Savara is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Pauls, with a market cap of $1.2B.
Common questions about Savara
Savara is scheduled to report earnings for Q1 2026 on May 12, 2026.
Savara has approximately 37 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.